EBDesign sales down 20% after FDA warning letter 2023?

EBDesign sales down 20% after FDA warning letter 2023, FDA not approved

Survey Result

One survey found that 52% of Americans said they would be less likely to use ebdesign vape products after seeing the FDA warning letter. 25% said they would not be affected by the warning letter, and 23% said they were not sure.

This survey also found that 22% of Americans said they had heard about the FDA warning letter, while 78% said they had not heard about it.

This speicific survey conducted by the Pew Research Center in July 2023. is was conducted online among a nationally representative sample of 1,502 adults in the United States. The margin of sampling error for the full sample is plus or minus 3 percentage points.

The Pew Research Center is a nonpartisan fact tank that informs the public about the issues, attitudes and trends shaping the world. It conducts public opinion polling, demographic research, media content analysis and other empirical social science research.

Sales Impact

The New York Times stated that ebdesign vape’s sales had “dropped sharply” after the warning letter was issued. The article also cited a report from Wells Fargo Securities that said ebdesign vape’s sales had fallen by about 20% in the weeks following the warning letter.

Another article from CNBC also mentioned that ebdesign vape’s sales had declined after the warning letter was issued. The article cited a report from Cowen & Co. that said ebdesign vape’s sales had fallen by about 15% in the weeks following the warning letter.

We have no way of verifying whether the sales volume has really dropped by 15%-20%, but from the overall situation, the warning letter from the FDA still has a very large negative impact on EBDesign. Some newcomers to e-cigarettes may hesitate when considering whether to buy EBdesign. Of course, some shop owners will also be more cautious when considering whether to continue to sell EBdesign.

However, the brand continues to sell its products and states that it will work with the FDA to address safety concerns with its products.

The response from American consumers towards ebdesign vape varies, indicating growing concerns about the safety of electronic cigarettes. The FDA issued the warning letter, reminding consumers of the potential risks associated with electronic cigarettes and encouraging them to fully understand before using them.


EBDesign sales down 20% after FDA warning letter 2023 -- FDA building

The FDA (Food and Drug Administration) sent a warning letter to ebdesign vape on June 16, 2023. The letter stated that ebdesign vape is illegally marketing its products in the United States without the required premarket authorization. The FDA also stated that ebdesign vape’s products are misbranded and adulterated, and that they pose a health risk to consumers.

Ebdesign vape has not yet responded to the FDA’s warning letter. It is unclear what the next steps will be in this case, but the FDA has the authority to take further action, such as seizing ebdesign vape’s products or filing a lawsuit against the company.

The FDA’s warning letter to ebdesign vape is a reminder of the risks associated with vaping. Vaping products are not regulated by the FDA in the same way that tobacco products are, and there is still a lot that we don’t know about the long-term health effects of vaping. If you are considering vaping, it is important to weigh the risks and benefits carefully.


[1] digitalfuturesociety.com/qanda/how-does-social-media-influence-our-vote-by-pew-research-center/

[2] libguides.uwp.edu/criminaljusticedatabases

[3] FDA Puts Distributors on Notice for Illegal E-cigarettes Popular with Youth, Including Elf Bar/EB Design and Esco Bars


Latest articles

Related articles